Mode
Text Size
Log in / Sign up
Phase 4 Completed N=58 Randomized Quadruple-blind Treatment

Study of the Insomnia in Patients With Low Back Pain

Source: ClinicalTrials.gov NCT00365976 ↗
Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Jun 2013
Primary outcomePrimary: Mean Subjective Sleep Diary Derived Total Sleep Time (TST) — 316.96; 380.45; 403.47; 375.56 Minutes

Summary

The purpose of this study is to examine whether insomnia due to chronic low back pain can improve with use of eszopiclone.

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Subjective Sleep Diary Derived Total Sleep Time (TST)
316.96; 380.45; 403.47; 375.56; 421.97; 382.11
SECONDARY
Visual Analog Scale Pain Ratings (VAS)
48.51; 53.79; 40.72; 51.99; 34.70; 51.25
SECONDARY
Mean Sleep Onset Latency (SOL)
38.28; 34.11; 22.36; 27.00; 17.50; 23.10
SECONDARY
Wake Time After Sleep Onset
91.51; 81.43; 49.34; 76.71; 37.07; 81.32
SECONDARY
Number of Awakenings
2.29; 2.08; 1.31; 1.98; 1.35; 2.13
SECONDARY
Sleep Quality Ratings
4.52; 4.44; 5.99; 4.90; 6.18; 5.33
SECONDARY
Insomnia Severity Index (ISI)
18.85; 20.26; 18.00; 16.78; 11.28; 12.85
SECONDARY
Patient Global Impression of Pain Ratings
4.02; 3.90; 3.54; 3.82; 3.30; 4.01
SECONDARY
Roland Morris Low Back Pain Inventory (RMLBPI)
12.27; 11.33; 9.97; 10.30; 9.10; 9.05
SECONDARY
Hamilton Depression Rating Scale (HAM-D-24)
6.45; 7.10; 6.38; 6.57; 4.54; 5.53
SECONDARY
Short Form 36 Health Survey Questionnaire (SF-36)
SECONDARY
State-Trait Anxiety Inventory (STAI)

Eligibility Criteria

Inclusion Criteria

  • • Diagnosis of insomnia based on DSM-IV criteria for insomnia due to a general medical condition (low-back pain);
  • The insomnia must not predate the onset of low-back pain by more than 1 month;
  • Usual nightly TST (Total Sleep Time) 30 minutes for the last month prior to screening;
  • ISI (Insomnia Severity Index) > 14 (at least moderate insomnia);
  • Age 21-64 years;
  • Greater than 40 on VAS (Visual Analog Scale) for pain (scale is 0-no pain to 100-worst imaginable pain);
  • Patient Global Impression of Pain of at least 3 (on a 1-5 scale, indicating at least moderate severity);
  • reported Back pain must be greater than reported leg pain, and there must be no signs of spinal nerve root compression;
  • presence of normal motor strength on exam;
  • duration of chronic low back pain of greater than three months;
  • low back pain location must be inferior to T12 and superior to the gluteal fold.

Exclusion Criteria

  • • Significant medical or neurological illness in excess of that which is directly responsible for the chronic low back pain;
  • the presence of an active and significant psychiatric disease with a substantive impact on sleep;
  • meeting DSM-IV criteria for an Axis I disorder within the last three months, or meeting criteria for substance abuse within the last 12 months;
  • current pregnancy; history of hypersensitivity, intolerance, or contraindication to Naproxen/Lansoprazole or Eszopiclone;
  • baseline creatinine of 2.0 or greater; patient taking other medications having significant renal effects (e.g. lithium, ACE inhibitor, angiotensin receptor antagonist, or thiazide/loop diuretics);
  • patients taking other anticoagulants; patients having an allergy to aspirin; history of diagnosed gastric or duodenal ulcer;
  • history of bleeding or clotting diathesis; lifetime history of myocardial infarction or cerebrovascular accident;
  • Elevated PT/PTT/INR (Prothrombin Time, Partial Thromboplastin Time, International Normalized Ratio)at screening;
  • Abnormal kidney function detected in screening labs;
  • history of back related surgery within the past 3 months; history of corticosteroid use in the past 30 days;
  • presence of currently pending litigation or worker's compensation claim related to the chronic low back pain;
  • inability to follow study procedures or complete the study; or the use of any medications that could affect sleep within 5 half-lives of screening;
  • history of back surgery within the past 2 years with the exception of a discectomy;
  • pregnant or lactating females;
  • women of child-bearing potential who will not agree to use approved means of birth control during the trial;
  • history of any surgery within the past one month; history of any major physical trauma within the last 6 months;
  • history of corticosteroid use within the last 90 days; diagnosis of rheumatoid or psoriatic arthritis;
  • history of fibromyalgia;
  • presence of spondyloarthropathy;
  • presence of sciatica;
  • spinal stenosis;
  • presence of any vertebral fractures, spondylolisthesis; or radicular back pain.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00365976). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search